Insider Transactions in Q2 2024 at Inovio Pharmaceuticals, Inc. (INO)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2024
|
Michael John Sumner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,917
+26.19%
|
-
|
|
May 15
2024
|
Peter Kies CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,562
-9.51%
|
$33,306
$13.07 P/Share
|
|
May 15
2024
|
Peter Kies CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,771
+15.05%
|
-
|
|
May 15
2024
|
Jay Shepard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,166
+23.52%
|
-
|
|
May 15
2024
|
Simon X Benito Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,166
+17.77%
|
-
|
|
May 15
2024
|
Ann Calby Miller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,166
+21.93%
|
-
|
|
May 15
2024
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,166
+2.56%
|
-
|
|
May 15
2024
|
Michael John Sumner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,386
+31.04%
|
-
|
|
May 15
2024
|
Laurent Humeau Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,703
-6.54%
|
$22,139
$13.07 P/Share
|
|
May 15
2024
|
Laurent Humeau Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,771
+15.48%
|
-
|
|
May 15
2024
|
Roger D Dansey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,166
+24.3%
|
-
|
|
May 15
2024
|
Lota S. Zoth Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,166
+24.83%
|
-
|
|
May 15
2024
|
Wendy L Yarno Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,166
+20.61%
|
-
|
|
May 15
2024
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,718
-18.66%
|
$100,334
$13.07 P/Share
|
|
May 15
2024
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,745
+30.02%
|
-
|
|
May 13
2024
|
Roger D Dansey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+17.91%
|
-
|
|
May 10
2024
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,392
-9.2%
|
$23,920
$10.65 P/Share
|
|
May 10
2024
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+17.45%
|
-
|